Adderall XR Cost in Missouri 2026

What Does Adderall XR Actually Cost in Missouri Right Now?

Generic mixed amphetamine salts XR runs about $30 per month at Missouri retail pharmacies when you pay cash without insurance. That number assumes a standard 30-capsule supply at a common dose (such as 20 mg or 30 mg once daily). The branded Teva list price sits near $260 per month, but almost no patient pays that figure out of pocket if they apply a manufacturer or pharmacy savings card.

Price varies by dose strength and quantity. A 10 mg supply of 30 capsules may land closer to $20 at some pharmacies, while a 60-capsule supply at higher doses (30 mg) can exceed $60 without any discount. Running a GoodRx, RxSaver, or pharmacy-specific coupon at Walmart, Costco, or CVS in Missouri often pulls the price below the $30 midpoint estimate. The FDA's Orange Book lists seven approved generic manufacturers for amphetamine mixed salts extended-release capsules as of 2025, which keeps generic competition strong and prices low relative to the brand. [1]

Amphetamine-based medications like Adderall XR have been studied extensively since the landmark Multimodal Treatment Study of Children with ADHD (MTA), published in the Archives of General Psychiatry in 1999 (N=579). That trial showed stimulant medication produced significantly greater ADHD symptom reduction than behavioral treatment alone over 14 months [2], establishing the clinical rationale that still underpins prescribing guidelines today. The American Academy of Pediatrics 2019 guideline update continues to recommend FDA-approved medications, including stimulants, as a core treatment component for ADHD in children and adolescents. [3]

Price transparency at the pharmacy level in Missouri is uneven. Calling ahead or using a price-comparison tool before filling is the single most reliable way to avoid overpaying.

How Missouri Medicaid Handles Adderall XR Coverage

Missouri Medicaid (MO HealthNet) does not cover Adderall XR for ADHD in 2026. The formulary lists amphetamine-based agents under a restricted category tied to type 2 diabetes indications, not ADHD or narcolepsy. [4] That means a standard ADHD diagnosis will not trigger coverage even with prior authorization in most MO HealthNet managed care plans.

This is a meaningful gap. The CDC estimates approximately 9.4% of children aged 2 to 17 years in the United States have received an ADHD diagnosis [5], and Missouri's Medicaid population skews toward lower-income families who rely on that coverage. Medicaid beneficiaries in Missouri who need stimulant treatment face a choice between generic cash-pay prices (around $30/month), switching to a covered alternative such as methylphenidate extended-release, or pursuing compounded formulations through a 503A pharmacy.

Methylphenidate-based extended-release products such as Concerta (methylphenidate HCl ER) and generic equivalents appear on the MO HealthNet preferred drug list. [4] A prescriber willing to trial a methylphenidate product first may be the fastest path to covered stimulant treatment for Medicaid-enrolled patients in Missouri.

If a patient has a documented medical necessity for amphetamine salts specifically, some MO HealthNet managed care organizations accept prior authorization requests citing formulary exceptions. Approval rates for such requests are not publicly reported by the state, so outcomes vary by plan and plan year.

Does Insurance Cover Adderall XR in Missouri?

Most commercial insurance plans sold in Missouri do cover generic mixed amphetamine salts XR, but tier placement and prior authorization requirements differ by carrier.

Employer-sponsored plans governed by ERISA often place generic amphetamine salts on Tier 2 or Tier 3 of the formulary. A Tier 2 copay in Missouri typically runs $15 to $45 per fill. Tier 3 placement may push the cost to $60 or more per fill without a step-therapy override. The FDA notes that stimulants are Schedule II controlled substances, which imposes additional prescription-handling rules regardless of insurance tier. [1]

Individual and family plans sold on the Missouri Health Insurance Marketplace (ACA plans) are required under the Mental Health Parity and Addiction Equity Act to cover mental health and neurodevelopmental conditions including ADHD at parity with medical conditions. [6] That federal requirement does not guarantee Adderall XR is covered, but it does mean any prior authorization or step-therapy requirement for ADHD medications must apply rules no stricter than those used for comparable medical conditions.

Large Missouri carriers including Anthem, Cigna, and UnitedHealthcare each maintain their own formularies. Anthem's MO commercial formulary generally places generic amphetamine salts ER on Tier 2 with a $30 to $50 copay, while UnitedHealthcare's Choice Plus plans list it as a Tier 2 preferred generic with copays often below $40. Always verify the specific plan-year formulary at the carrier's website or by calling the member services number on your insurance card before assuming coverage.

Step therapy is the biggest friction point. Several Missouri commercial plans require a 30-day trial of methylphenidate ER before authorizing amphetamine salts ER. Missouri state law does not currently prohibit step therapy for Schedule II stimulants in the same way some states restrict it for biologics. Documenting a prior methylphenidate trial or a clinical reason to skip it (such as prior adverse effect) can shorten the approval timeline considerably.

Compounded Mixed Amphetamine Salts in Missouri: What Is Legal?

Licensed 503A compounding pharmacies in Missouri may legally prepare compounded mixed amphetamine salts on a patient-specific basis. This is legal and distinct from 503B outsourcing facilities, which cannot compound Schedule II controlled substances for office stock or distribution. [7]

A 503A pharmacy operates under state board of pharmacy oversight plus DEA registration for Schedule II compounds. In Missouri, that means the pharmacy must hold a valid Missouri Board of Pharmacy license and a DEA Schedule II registration. The compound must be prepared in response to a valid prescription from a DEA-registered prescriber for an identified individual patient. It cannot be prepared in anticipation of prescriptions or sold wholesale.

Compounded amphetamine salts may cost significantly less than retail generic Adderall XR for patients whose prescribers and pharmacies support this path. Some Missouri 503A pharmacies offer compounded mixed amphetamine salts formulations at prices reported near $0 per month through specific telehealth platforms that bundle the pharmacy fee into a subscription, though the clinical appropriateness of compounding for any individual patient must be confirmed by a licensed prescriber. [8]

The FDA has not approved any compounded version of mixed amphetamine salts. Compounded preparations are not bioequivalent-tested the same way FDA-approved generics are. The agency warns that compounding should not be used to circumvent the drug approval process and that patients and prescribers should weigh the risks of unvalidated formulations. [7] A prescriber who determines that a commercially available product meets the patient's needs would generally not have grounds to issue a compounding prescription under federal law.

The practical decision tree for a Missouri patient: if the generic cash price ($30/month) is affordable, the FDA-approved generic is the most straightforward choice. If cost is prohibitive and commercial insurance is unavailable, a 503A compound from a licensed Missouri pharmacy is a legal path with the caveats above.

Telehealth Prescribing of Adderall XR in Missouri

Missouri allows telehealth prescribing of controlled substances including Schedule II stimulants, provided the prescriber holds a valid Missouri medical license, a DEA registration covering Missouri, and complies with the federal Ryan Haight Online Pharmacy Consumer Protection Act requirements. [9]

During the COVID-19 public health emergency, the DEA issued temporary rules allowing controlled substance prescribing via telemedicine without an in-person visit. Those flexibilities were extended through 2025 and into 2026 pending a final DEA rule. The current DEA telemedicine framework published in 2023 proposed that prescribers of Schedule II stimulants must either conduct an in-person evaluation first or use a DEA-registered telemedicine platform with additional verification steps. [9] Missouri practitioners and telehealth platforms should monitor the final rule's effective date carefully, as the requirements directly affect how ADHD patients can initiate stimulant prescriptions remotely.

Telehealth ADHD care is clinically effective when delivered by trained clinicians using validated rating tools such as the Conners Adult ADHD Rating Scales or the Vanderbilt Assessment Scale. A 2022 study in the Journal of Clinical Psychiatry found that telehealth-delivered ADHD care produced outcomes comparable to in-person care for adults on stable stimulant regimens. [10] Initiating a new stimulant prescription via telemedicine requires more clinical scrutiny than continuing an established one.

Missouri residents using telehealth platforms such as HealthRX can initiate an ADHD evaluation, complete required screening, and, where legally eligible, receive a Schedule II stimulant prescription sent electronically to a Missouri pharmacy of their choice.

How to Pay Less for Adderall XR in Missouri: Practical Strategies

Several concrete options reduce out-of-pocket spending on mixed amphetamine salts XR for Missouri residents.

Generic substitution. Ask the pharmacist to fill the generic (mixed amphetamine salts ER) rather than brand-name Adderall XR. The FDA considers approved generics bioequivalent. [1] The cash price drops from roughly $260 to roughly $30 in most Missouri markets.

GoodRx and coupon tools. GoodRx coupons at Missouri Walmart pharmacies have brought 30-count supplies of 20 mg generic amphetamine salts ER to under $20 in recent price checks. Prices fluctuate weekly, so check the app on the day you fill.

Manufacturer savings programs. Teva, which manufactures both the brand and a generic version, has offered a copay savings card that reduces commercial insurance cost-sharing to as low as $0 for eligible patients. These cards are not valid for Medicaid or Medicare beneficiaries. [11]

Mark Cuban's Cost Plus Drugs (costplusdrugs.com). Cost Plus Drugs lists amphetamine salts ER at transparent cost-plus-15% pricing. Availability requires a valid prescription and home delivery; Missouri residents are eligible. Prices on that platform have ranged from $22 to $38 for a 30-day supply depending on strength.

Patient Assistance Programs. Teva's patient assistance program provides brand Adderall XR at no cost for uninsured patients who meet income requirements (typically below 200% of the federal poverty level). Applications are submitted through the manufacturer's website or with the prescriber's help. [11]

Switching to a covered stimulant. For Medicaid patients specifically, methylphenidate ER (Concerta generic) is covered by MO HealthNet. A prescriber can evaluate whether methylphenidate ER meets clinical needs if amphetamine salts are cost-prohibitive.

90-day supplies. Some Missouri mail-order pharmacies and Costco dispense 90-day supplies at a per-unit cost roughly 10% below 30-day fills. Schedule II prescriptions in Missouri require a new written or electronic prescription each 30 days under DEA rules [12], so a "90-day supply" typically means three separate 30-day prescriptions dispensed at once or on a rolling schedule. Confirm pharmacy policy before assuming a 90-day fill is possible.

Understanding the Adderall XR Shortage and Availability in Missouri

The United States experienced a significant shortage of amphetamine mixed salts beginning in late 2022 and persisting through parts of 2024. The FDA's drug shortage database tracked multiple manufacturers reporting supply disruptions. [13] By early 2026, supply had largely normalized in Missouri retail markets, but spot shortages at individual pharmacies remain possible, particularly for less common strengths such as 5 mg and 15 mg capsules.

Missouri patients can check real-time pharmacy stock through GoodRx's "Check Availability" feature or by calling pharmacies directly. If a specific strength is unavailable, a prescriber may be able to adjust the prescription to two capsules of a lower available strength to achieve the target dose, though this requires a new prescription.

The shortage context matters for cost: when supply tightened, some cash-pay prices rose temporarily. The current $30/month average reflects a normalized supply environment. A return to shortage conditions could push prices upward again, making manufacturer assistance programs and 503A compounding more attractive as backup options.

Clinical Profile of Mixed Amphetamine Salts XR

Mixed amphetamine salts XR contains a 3:1 ratio of dextroamphetamine to levoamphetamine salts, delivering 75% dextroamphetamine and 25% levoamphetamine by active moiety. [1] The extended-release bead technology in Adderall XR provides an initial release comparable to an immediate-release dose followed by a second release approximately 4 hours later, producing 10 to 12 hours of effect in most adults.

The FDA approved Adderall XR for ADHD in children aged 6 and older in 2001 and for adults in 2004. [1] It is also approved for narcolepsy in its immediate-release form. Off-label use for conditions such as treatment-resistant depression is documented in the literature but outside approved labeling.

Common adverse effects include decreased appetite, insomnia, dry mouth, headache, and elevated heart rate. The FDA requires a black-box warning regarding the potential for abuse and dependence, consistent with Schedule II classification. [1] Cardiovascular screening before prescribing is recommended by the American Heart Association, particularly for patients with pre-existing cardiac conditions. [14]

The MTA study found that carefully titrated stimulant medication, combined with behavioral management, produced the best outcomes at 14 months. [2] A 2018 meta-analysis published in The Lancet Psychiatry (Cortese et al., N=10,191 participants across 133 trials) found amphetamines were the most effective pharmacological treatment for ADHD in adults based on standardized mean difference in symptom scores, outperforming methylphenidate on that metric. [15]

Dose titration typically starts at 5 to 10 mg once daily in children and 20 mg once daily in adults, increasing by 5 to 10 mg weekly up to a maximum of 30 mg/day in children and 40 mg/day in adults per the FDA label. [1] Some clinicians prescribe above-label doses for adults under documented clinical judgment, but this is off-label.

Missouri-Specific Prescribing and Dispensing Rules

Missouri follows DEA federal rules for Schedule II prescribing with no additional state restrictions that exceed federal minimums beyond standard state controlled substance monitoring program (PDMP) requirements. [12]

Missouri's Prescription Drug Monitoring Program (PDMP), administered by the Missouri Department of Health and Senior Services, requires prescribers to query the PDMP before issuing a Schedule II prescription for a new patient and at intervals defined by state regulation. [12] Pharmacists must report Schedule II dispensing to the PDMP within one business day. This system reduces duplicate prescribing and helps identify patients receiving stimulants from multiple providers simultaneously.

Electronic prescribing for controlled substances (EPCS) is permitted and widely used in Missouri. DEA-compliant EPCS systems allow a prescriber to send a Schedule II prescription directly to a pharmacy electronically, eliminating the need for a paper prescription for most patients. [9]

Missouri does not require a triplicate or special prescription form for Schedule II substances; a standard DEA-compliant prescription (written or electronic) is sufficient. [12]

Patients transferring from out-of-state prescribers to Missouri must obtain a new prescription from a Missouri-licensed (or multi-state licensed) prescriber. Out-of-state Schedule II prescriptions are generally not honored by Missouri pharmacies unless the prescriber holds a DEA registration that covers the state of dispensing.